Pharming Income Statement (2018-2026) | PHAR

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2018 Dec2019 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue (Quarter)
0.05B-0.14B0.05B0.05B0.05B0.15B0.04B54,900.00B0.07B81.200.06B0.13B74.80204.500.08B172.320.10B0.11B0.000.16B
Cost of Revenue (Quarter)
0.02B-0.01B0.00B0.05B0.00B0.01B0.00B5,700.00B0.01B0.03B8.390.02B6,800.00B0.04B0.01B0.02B7,100.00B21,100.00B0.000.02B
Gross Profit (Quarter)
0.05B0.08B0.04B0.05B0.05B0.14B0.04B0.09B0.06B146,000.00B0.05B0.11B0.07B181,300.00B70.770.16B0.09B0.09B0.000.14B
Operating items
Research & Development (Quarter)
-0.01B0.04B-0.01B-0.05B-0.02B-20.90-0.02B-57.30-0.02B-0.04B-20.70-0.08B-0.02B-0.04B-23.40-0.10B-0.03B-0.06B
Selling, General & Administrative (Quarter)
-0.01B0.02B-0.01B-0.05B-0.01B-11.00-0.01B-31.90-0.02B-0.03B-15.30-0.07B-0.02B-0.04B-17.00-0.08B-0.02B-0.03B
Operating Expenses (Quarter)
-0.02B0.06B-0.02B-0.10B-0.03B-31.90-0.03B-89.20-0.03B-0.07B-36.00-0.15B-0.04B-0.09B-40.40-0.18B-0.04B-0.09B
Operating Income (Quarter)
-0.00B0.02B0.00B0.02B0.01B0.03B-0.01B-0.01B0.00B-6.50-0.02B-19.434,100.00B-15300.00B-7.043.810.02B0.01B0.00-0.00B
EBIT (Quarter)
-0.00B-0.01B0.00B0.02B0.01B0.03B-0.01B-0.01B0.00B-6.50-0.02B-19.434,100.00B-15300.00B-7.043.810.02B0.01B0.00-0.00B
Non-operating items
Non Operating Interest Expenses (Quarter)
0.00B0.00B0.00B-0.00B
Non Operating Investment Income (Quarter)
-0.00B-0.00B-0.00B0.00B0.01B0.00B-0.20
Other Non Operating Income (Quarter)
0.02B-0.01B0.00B0.01B0.00B-0.00B-0.00B-0.00B0.00B0.00B0.00B-0.01B0.00B0.00B-0.00B-0.00B0.00B0.01B
Non Operating Income (Quarter)
0.00B-0.00B-0.00B0.00B-0.01B0.00B0.00B-0.00B0.00B-0.00B-0.01B0.00B-0.01B0.00B0.00B
Net income details
EBT (Quarter)
-0.02B0.01B0.00B0.02B0.01B0.03B-0.01B-0.01B0.00B-0.01B-0.02B-19.430.00B-0.01B-0.02B3.810.03B4.80-0.01B0.03B
Tax Provisions (Quarter)
-0.00B0.01B-0.00B-0.00B-0.00B-0.00B0.00B-2.100.00B2.600.00B0.00B-2.50-0.00B-0.00B-0.01B-5.200.50-0.00B-0.00B
Profit After Tax (Quarter)
-0.00B0.01B0.00B0.02B-0.02B0.01B-0.02B-0.01B0.00B-0.01B-0.02B-0.00B0.00B-0.01B-0.01B0.01B0.03B-0.01B-0.01B0.03B
Equity Income (Quarter)
0.00B-0.01B
Income from Non-Controlling Interests (Quarter)
-0.00B-0.00B0.00B-0.00B
Income from Continuing Operations (Quarter)
-0.02B0.02B0.00B0.02B0.01B0.04B-0.02B-0.01B0.00B-0.01B-0.02B-0.00B0.00B-0.01B-0.01B0.01B0.03B4.30-0.01B0.03B
Consolidated Net Income (Quarter)
-0.02B0.02B0.00B0.02B0.01B0.04B-0.02B-0.01B0.00B-0.01B-0.02B-0.00B0.00B-0.01B-0.01B0.01B0.03B4.30-0.01B0.03B
Income towards Parent Company (Quarter)
-0.02B0.02B0.00B0.02B0.01B0.03B-0.01B1.300.00B-7.40-0.01B-0.01B-1.10-14.70-0.01B-0.01B-0.01B5.30-0.01B-0.01B
Net Income towards Common Stockholders (Quarter)
-0.02B0.02B0.00B0.02B0.01B0.03B-0.01B1.300.00B-7.40-0.01B-0.01B-1.10-14.70-0.01B-0.01B-0.01B5.30-0.01B-0.01B
Additional items
EPS (Basic) (Quarter)
-0.030.020.010.020.010.04-0.020.000.010.00-0.02-0.020.000.00-0.02-0.01-0.020.00-0.02-0.02
EPS (Diluted) (Quarter)
-0.030.020.010.020.010.04-0.020.000.000.00-0.02-0.020.000.00-0.02-0.01-0.020.00-0.02-0.01
Shares Outstanding (Quarter)
0.64B0.64B0.64B0.64B0.66B0.65B0.65B0.65B0.65B0.66B0.66B0.66B0.66B0.67B0.67B0.67B0.67B0.69B0.69B0.69B
Shares Outstanding (Diluted) (Quarter)
0.68B0.70B0.70B0.70B0.72B0.71B0.71B0.71B0.71B0.73B0.73B0.73B0.73B0.79B0.79B0.79B0.79B0.75B0.75B0.75B
Shares Outstanding (Entity) (Quarter)
0.65B0.66B0.67B0.68B0.70B
EBITDA (Quarter)
-0.00B-0.01B0.00B0.02B0.01B0.03B-0.01B-0.01B0.00B-6.50-0.02B-19.434,100.00B-15300.00B-7.043.810.02B0.01B0.00-0.00B
Interest Expenses (Quarter)
0.00B0.00B0.00B-0.00B
Tax Rate (Quarter)
8.95%55.29%-28.57%-21.28%-2.15%-14.50%-32.69%0.00%4.75%0.00%-25.60%-15,530,283.54%0.00%39.44%19.22%-147,936,925.10%0.00%10.42%3.12%-7.12%